(Q41699354)

7 October 2017

1 reference

title

Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines (English)

1 reference

7 October 2017

Ferrara JL

1

1 reference

7 October 2017

Krenger W

series ordinal

2

1 reference

7 October 2017

language of work or name

1 reference

1 January 1998

1 reference

Transfusion Medicine Reviews

7 October 2017

published in

1 reference

7 October 2017

volume

12

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

1-17

1 reference

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Cytokine dysregulation as a mechanism of graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

T lymphocyte subsets, cytokines, and effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

The functional role of CD8+ T helper type 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: their activation and effector functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

IL-12: initiation cytokine for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Lymphokine production by human T cells in disease states

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

1 reference

7 January 2021

Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

1 reference

7 January 2021

Macrophage activation by T cells: cognate and non-cognate signals

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin 10 protects mice from lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Molecular regulation of the IL-2 gene: rheostatic control of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Th1 and Th2 subsets: paradigms lost?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Critical role of interleukin-2 in the development of acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Cytokine gene expression in mice undergoing chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Lethal murine graft-versus-host disease in the absence of detectable cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Differential cytokine expression in acute and chronic murine graft-versus-host-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

A study of cytokine production in acute graft-vs-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Quantitative analysis of lymphokine expression in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Role of cytokines and major histocompatibility complex antigens in graft-versus-host disease: in vitro studies using T-cell lines and keratinocytes or hemopoietic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Evidence that IFN-gamma is responsible for natural suppressor activity in GVHD spleen and normal bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Apoptosis of murine large intestine in acute graft-versus-host disease after allogeneic bone marrow transplantation across minor histocompatibility barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Nitric oxide synthases: Roles, tolls, and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Nitric oxide mediates intestinal pathology in graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Nitric oxide--a new endogenous immunomodulator.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Hyper IgE in stimulatory graft- versus-host disease: role of interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

IL4 dictates T-cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Inhibition of nitric oxide synthesis by interleukin‐4 may involve inhibiting the activation of protein kinase C epsilon

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

Graft-versus-host disease in experimental allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980085-0

7 January 2021

10.1016/S0887-7963(98)80085-0

Identifiers

DOI

1 reference

7 October 2017

1 reference